Treatment Study - Intake Form |
Thank you for your interest in the research study, Hereditary Breast Cancer Treatment Study (Treatment Study for short).
The purpose of the Treatment Study is to collect information on hereditary breast cancers in individuals with ATM, CHEK2 and PALB2 mutations. Our goal is to understand how these cancers are discovered; how these cancers develop and physically affect women; and how these cancers are treated. The study will look at the 5- and 10-year outcomes of ATM-, CHEK2-, and PALB2-associated breast cancer for all participants to learn about factors that may predict cancer survival. The study uses questionnaires to collect information about breast cancer diagnosis, treatment, and genetic testing history. We will also request your medical records from the hospitals where you received care.
Please complete the following intake form to confirm your eligibility and proceed with enrolling in the study. Your responses will be saved in our secure research database called REDCap (Research Electronic Data Capture) stored on Women's College Hospital servers (Toronto, Canada).
If you have any questions for the study team or would prefer to share this information by email or phone, please contact us at TreatmentStudy@wchospital.ca or 416-323-6400 x5125 or x2749.